New Delhi, India – 110 016

South Delhi Pharma, New Delhi, India

IMJUDO (tremelimumab-actl) injection

This specialty medication is authorized and manufactured internationally and is not registered or commercially distributed for retail sale in India. To verify patient eligibility, check international supply availability, or understand the regulatory logistics and documentation process: Call our Compliance Desk at 9891296838 or Email your Inquiry query@southdelhipharma.com.

INDICATIONS AND USAGE
Imjudo (tremelimumab) is a cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) blocking antibody indicated only in combination with Imfinzi (durvalumab), for the treatment of adult patients with unresectable hepatocellular carcinoma (uHCC).
DOSAGE FORMS & STRENGTHS: Injection: 25 mg/1.25 mL (20 mg/mL) solution in a single-dose vial.
Injection: 300 mg/15 mL (20 mg/mL) solution in a single-dose vial.
Manufactured By: AstraZeneca Pharmaceuticals LP
Prescribing Information URL: Click Here

IMJUDO (tremelimumab-actl) injection, a FDA approved prescription medicine can be accessed in India and other part of countries. South Delhi Pharma can facilitate the supply on request under Named Patient Program by fulfilling the legal requirement (if applicable) on behalf patient. Share your mobile number and email ID to get “tremelimumab-actl injections” cost price in India.

Category
IMJUDO (tremelimumab-actl) injection cost Price In India
Category

Disclaimer: Trademark shown are property of their respective owners and South Delhi Pharma (SDP) India does not lay any claim on them.

Get In Touch

South Delhi Pharma is dedicated to facilitating access to critical, globally approved pharmaceutical therapies tailored to individual patient needs. Established in 1996, It has built a trusted reputation for assisting patients and healthcare institutions in navigating the regulatory frameworks required to securely source high-quality, international life-saving medications.

The SDP is open
Monday to Friday.
Business hours: 09:30 A.M to 18:30 P.M.

Contact Number:
M:+91-9891296838 / P:+91-11- 26532129

Email ID:
info@southdelhipharma.com

Query Form

This is an inquiry and facilitation request form. Submission does not constitute a sale, purchase order, or guarantee of medicine availability.

Note: Notice for Sourcing Inquiries

Description

Medical Uses tremelimumab-actl injection

Tremelimumab is indicated, in combination with durvalumab, for the treatment of adults with unresectable hepatocellular carcinoma. Tremelimumab, sold under the brand name Imjudo, is a fully human monoclonal antibody against CTLA-4. It is an immune checkpoint blocker. Tremelimumab was approved for unresectable hepatocellular carcinoma medical use in the United States in October 2022.

Get Access To IMJUDO (tremelimumab-actl) injection In India

Brand Name “IMJUDO (tremelimumab-actl) injection” or Generic Name “pegfilgrastim-fpgk injection” can be imported for personal use under “Named Patient Program” treatment in Delhi, Mumbai, Kolkata, Chennai, Bangalore, Hyderabad, Ahmedabad, Pune, Surat, Jaipur, Coimbatore, Noida, Gurgaon, Punjab, Chandigarh, Bhubaneswar, Arunachal Pradesh, Assam, Manipur, Meghalaya, Mizoram, Nagaland, Tripura and Sikkim, India. Contact us at support@southdelhipharma.com, southdelhipharma@gmail.com or call/WhatsApp at +91-9891296838 to get access as per norms.

Pharma Services and Drug Inquiries

Our Pharma Division deals only with the best, GMP certified generics and branded medication for the export market. All our products are supported by strict adherence to quality and analysis certification.

Please note for the minimum order for Exports is of US$ 300. All orders will be subject to courier charges and supplies are normally dispatched through internationally accredited courier services.

Complete the form below to receive the no-obligation price quote.

Disclaimer

Note : We do not supply schedule-H (Example – narcotic drug or psychotropic drugs or anabolic steroids) and Anti- Abortion Drugs.

All Trademarks and Brands that appear on the website belong to their respective owners and South Delhi Pharma does not lay any claim on them we only provide Information. Following Information meant for Wholesalers, Suppliers, Exporters, Doctors, Comparator Supplies, Hospitals, Generic, Brand, Corporate Sourcing, reseller, and Pharmacies.

Global Network

South Delhi Pharma, Delhi India is a leading Pharmaceutical Distributor / Supplier / Exporter / Importer of Specialty Pharmaceutical drugs. Having more than 25 years of experience. Supplying innovator and generic anti cancer products at the most competitive prices. Contact us at support@southdelhipharma.com, southdelhipharma@gmail.com or call/WhatsApp at +91-9891296838 to get access as per norms.

Get Access In India

Delhi, Mumbai, Kolkata, Chennai, Bangalore, Hyderabad, Ahmedabad, Pune, Surat, Jaipur, Coimbatore, Noida, Gurgaon, Punjab, Chandigarh, Bhubaneswar, Arunachal Pradesh, Assam, Manipur, Meghalaya, Mizoram, Nagaland, Tripura and Sikkim, India.

Get Access In Overseas

Besides India, we have been able to cater medicines request coming from East Asia – China (Beijing, Chongqing, Shanghai, Tianjin and Shenzhen), Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong. United Arab Emirates – Iraq, Iran, Saudi Arabia, Jordan. North America – Mexico. South America – Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia. African Countries – Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand. Europe, USA, China, Australia, ASEAN countries and Latin American countries.

Related Products

Related products